Author

S. Rha

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Efficacy and Safety of GNX80 in Patients with Peripheral Arterial Disease and Intermittent Claudication.

BACKGROUND AND OBJECTIVES Peripheral arterial disease (PAD) is associated with intermittent claudication (IC), leading to a lower quality of life. Although Ginkgo biloba extract (GbE) has been investigated for the treatment of IC, its clinical efficacy remains controversial. This study aimed to evaluate the efficacy an...

Onyou Kim, Seung-Hun Lee, J. Kim et al. · Korean Circulation Journal · 0 citations

Open access Sep 2026

Clopidogrel monotherapy versus aspirin monotherapy in females and males after percutaneous coronary intervention: a sex-stratified analysis of the SMART-CHOICE 3 trial.

BACKGROUND Clopidogrel has emerged as a promising alternative to aspirin monotherapy for maintenance therapy after percutaneous coronary intervention (PCI); however, the optimal antiplatelet strategy according to sex remains controversial. AIMS We aimed to investigate whether the treatment effect of antiplatelet ther...

Woo-Duk Kwon, Ki H. Choi, Yonghwan Park et al. · EuroIntervention · 0 citations

Open access Aug 2026

Long-term clinical outcomes of carvedilol versus nebivolol in patients with ST-segment elevation myocardial infarction treated with second-generation drug-eluting stents: insights from a Korean nationwide multicenter prospective registry

Background Owing to the limited head-to-head comparative evidence between vasodilating β-blockers, this study aimed to assess long-term clinical outcomes of nebivolol vs. carvedilol in patients with ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) with second-genera...

Jihun Ahn, HyeYon Yu, S. Rha et al. · Frontiers in Cardiovascular... · 0 citations